• Pharmacy Job Market Webinar

    Are you considering applying to pharmacy school but are concerned about job prospects when you graduate? Join us on Wednesday, July 28th at 8 PM Eastern to hear from three PharmDs about their experiences and options outside of retail pharmacy.

peter90036

not out fishing
10+ Year Member
7+ Year Member
Jul 13, 2005
254
0
next to the pond
Status (Visible)
  1. Attending Physician
http://jama.ama-assn.org/cgi/content/short/300/18/2134

Results
A total of 154 atherosclerotic events occurred: 68 in the aspirin group (13.6 per 1000 person-years) and 86 in the nonaspirin group (17.0 per 1000 person-years) (hazard ratio
, 0.80; 95% confidence interval [CI], 0.58-1.10; log-rank test, P = .16).

The combined end point of fatal coronary events and fatal cerebrovascular events occurred in 1 patient (stroke) in the aspirin group and 10 patients (5 fatal myocardial infarctions and 5 fatal strokes) in the nonaspirin group (HR, 0.10; 95% CI, 0.01-0.79; P = .0037). A total of 34 patients in the aspirin group and 38 patients in the nonaspirin group died from any cause (HR, 0.90; 95% CI, 0.57-1.14; log-rank test, P = .67). The composite of hemorrhagic stroke and significant gastrointestinal bleeding was not significantly different between the aspirin and nonaspirin groups.

Conclusion
In this study of patients with type 2 diabetes, low-dose aspirin as primary prevention did not reduce the risk of cardiovascular events.

.......

me = huh? 68 vs 86, 1 vs 10 ...

i dont get it, why is the conclusion that it does not reduce the risk?
 
Last edited:

It'sElectric

Full Member
10+ Year Member
Dec 5, 2005
1,501
6
Status (Visible)
  1. Attending Physician
http://jama.ama-assn.org/cgi/content/short/300/18/2134

Results
A total of 154 atherosclerotic events occurred: 68 in the aspirin group (13.6 per 1000 person-years) and 86 in the nonaspirin group (17.0 per 1000 person-years) (hazard ratio
, 0.80; 95% confidence interval [CI], 0.58-1.10; log-rank test, P = .16).

The combined end point of fatal coronary events and fatal cerebrovascular events occurred in 1 patient (stroke) in the aspirin group and 10 patients (5 fatal myocardial infarctions and 5 fatal strokes) in the nonaspirin group (HR, 0.10; 95% CI, 0.01-0.79; P = .0037). A total of 34 patients in the aspirin group and 38 patients in the nonaspirin group died from any cause (HR, 0.90; 95% CI, 0.57-1.14; log-rank test, P = .67). The composite of hemorrhagic stroke and significant gastrointestinal bleeding was not significantly different between the aspirin and nonaspirin groups.

Conclusion
In this study of patients with type 2 diabetes, low-dose aspirin as primary prevention did not reduce the risk of cardiovascular events.

.......

me = huh? 68 vs 86, 1 vs 10 ...

i dont get it, why is the conclusion that it does not reduce the risk?



I could be wrong, but that conclusion is correct. It didn't significantly reduce the number of cardiovascular events, but it DID significantly reduce the number of fatal CV events.

It's stats...
 
This thread is more than 12 years old.

Your message may be considered spam for the following reasons:

  1. Your new thread title is very short, and likely is unhelpful.
  2. Your reply is very short and likely does not add anything to the thread.
  3. Your reply is very long and likely does not add anything to the thread.
  4. It is very likely that it does not need any further discussion and thus bumping it serves no purpose.
  5. Your message is mostly quotes or spoilers.
  6. Your reply has occurred very quickly after a previous reply and likely does not add anything to the thread.
  7. This thread is locked.